Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,458 | 13,880 | 12,930 | 14,275 | 12,984 |
| Other current assets | 1,000 | 0 | 0 | 0 | 0 |
| TOTAL | $16,999 | $14,682 | $13,368 | $14,589 | $13,280 |
| Non-Current Assets | |||||
| PPE Net | 457 | 509 | 562 | 615 | 668 |
| Intangibles | 419 | 421 | 424 | 426 | 428 |
| TOTAL | $876 | $931 | $986 | $1,041 | $1,096 |
| Total Assets | $17,875 | $15,612 | $14,354 | $15,630 | $14,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 868 | 953 | 826 | 604 | 594 |
| Accrued Expenses | 147 | 72 | 98 | 97 | 51 |
| Other current liabilities | 3,399 | 373 | 633 | 1,079 | 159 |
| TOTAL | $4,414 | $1,397 | $1,557 | $1,780 | $804 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,339 | N/A | N/A | N/A | N/A |
| TOTAL | $3,339 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,753 | $1,397 | $1,557 | $1,780 | $804 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,314 | 2,314 | 2,263 | 2,223 | 2,218 |
| Common Shares | 165 | 161 | 158 | 45 | 154 |
| Retained earnings | -36,119 | -32,437 | -31,228 | -29,424 | -27,780 |
| Other shareholders' equity | 11 | 10 | 10 | 3 | 9 |
| TOTAL | $10,122 | $14,215 | $12,797 | $13,850 | $13,572 |
| Total Liabilities And Equity | $17,875 | $15,612 | $14,354 | $15,630 | $14,376 |